Propofol for sedation for direct current cardioversion

dc.contributor.authorde Wafae, Bruna Galvãoen_US
dc.contributor.authorda Silva, Rose Mary Ferreiraen_US
dc.contributor.authorVeloso, Henrique Hortaen_US
dc.date.accessioned2019-12-02T09:45:42Z
dc.date.available2019-12-02T09:45:42Z
dc.date.issued2019-04
dc.description.abstractDirect current cardioversion is a low-risk and standard procedure to restore normal sinus rhythm in patients with tachyarrhythmias. It requires sedation to facilitate the procedure, as it is painful and distressful. The preferred anesthetic drug must be short acting, producing conscious sedation, to enable rapid recovery after the procedure. In this sense, this narrative review focuses on the critical analysis of recent randomized studies and presents about the safety and effectiveness of propofol, comparing it with other established sedatives, mainly etomidate and midazolam. The research was performed on MEDLINE database with Propofol and Cardioversion keywords. In most cases, propofol comes to be the best option, with a quick recovery time and low rates of side effects. Different studies have demonstrated no inferiority when comparing to other drugs and, when these adverse events happened, they were easily and quickly handled. Exceptions in this scenario are those patients, particularly the elderly, with baseline important structural heart disease, in which etomidate with fentanyl has been pointed to lead to better hemodynamic stability.en_US
dc.identifier.affiliationsMedical Sciences Faculty, State University of Rio de Janeiro, Rio de Janeiro, Brazilen_US
dc.identifier.affiliationsDepartment of Internal Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazilen_US
dc.identifier.affiliationsEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazilen_US
dc.identifier.citationde Wafae Bruna Galvão, da Silva Rose Mary Ferreira, Veloso Henrique Horta. Propofol for sedation for direct current cardioversion. Annals of Cardiac Anaesthesia. 2019 Apr; 22(2): 113-121en_US
dc.identifier.issn0971-9784
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/185885
dc.languageenen_US
dc.publisherWolters Kluwer - Medknowen_US
dc.relation.issuenumber2en_US
dc.relation.volume22en_US
dc.source.urihttps://dx.doi.org/10.4103/aca.ACA_72_18en_US
dc.subjectAnesthesiaen_US
dc.subjectatrial fibrillationen_US
dc.subjectcardioversionen_US
dc.subjectetomidateen_US
dc.subjectmidazolamen_US
dc.subjectpropofolen_US
dc.subjectsedationen_US
dc.titlePropofol for sedation for direct current cardioversionen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
aca2019v22n2p113.pdf
Size:
906.45 KB
Format:
Adobe Portable Document Format